Butterfly Therapeutics (Bliss DTx - Endocare) Revenue

Medical Equipment Manufacturing • Laval, Pays de la Loire, France • 1-10 Employees

Butterfly Therapeutics (Bliss DTx - Endocare) revenue & valuation

Annual revenue	$855,550
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues	$2,800,000
Total funding	No funding

Key Contact at Butterfly Therapeutics (Bliss DTx - Endocare)

Naomi Smith

Non-Executive Director

Company overview

Headquarters	106, Avenue Pierre de Coubertin, Laval, Pays de la Loire 53000, FR
Website	butterfly-therapeutics.com
NAICS	3391
Founded	2011
Employees	1-10
Socials

About Butterfly Therapeutics (Bliss DTx - Endocare)

Butterfly Therapeutics est une entreprise innovante qui se consacre au développement et au déploiement de thérapies numériques. Des solutions protocolisées à l’efficacité cliniquement prouvée pour la gestion et le traitement de la douleur, au-delà de la chimie. #BlissDTx est utilisée en complément ou en substitution des produits pharmacologiques et des gaz médicaux traditionnels lors de gestes médicaux douloureux et de chirurgies. #Endocare est utilisée pour le traitement des douleurs chroniques telles que celles liées à l’endométriose.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Entry

Manager

Employees by Department

Butterfly Therapeutics (Bliss DTx - Endocare) has 2 employees across 2 departments.

Departments

Number of employees

Funding Data

Butterfly Therapeutics (Bliss DTx - Endocare) has never raised funding before.

Frequently asked questions

Butterfly Therapeutics (Bliss DTx - Endocare) is located in Laval, Pays de la Loire, FR.

Butterfly Therapeutics (Bliss DTx - Endocare) generates an estimated annual revenue of $855,550. This revenue figure reflects the company's market position and business performance in its industry.

Butterfly Therapeutics (Bliss DTx - Endocare) has an estimated valuation of $2,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Butterfly Therapeutics (Bliss DTx - Endocare) was founded in 2011, making it 15 years old. The company has established itself as a significant player in its industry over this time.

Butterfly Therapeutics (Bliss DTx - Endocare) has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Butterfly Therapeutics (Bliss DTx - Endocare)

Naomi Smith

Non-Executive Director

4.8

40,000 users